NeuroRx, Inc. is a clinical stage, small molecule pharmaceutical company that excels at rapid development of already-known molecules to deliver lifesaving solutions in record time at minimum cost. The pharmaceutical industry routinely reports spending $1 billion or more to develop a new drug. We pride ourselves on developing lifesaving drugs that can be approved and brought to market for less than $50 million. Members of our team have developed first in class drugs for blinding eye disease, diabetes, depression, and now we are working in the area of COVID-19.
